Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 83 #1
CompanyAutobytel Inc.
IndustryInternet Information Providers
Market Cap188.12MEPS (ttm)0.34
P/E52.79EPS this Y-91.70%
Forward P/E13.99EPS next Y16.32%
PEG2.11EPS past 5Y22.40%
P/S1.78EPS next 5Y25.00%
P/B2.26EPS Q/Q75.00%
Dividend-Sales Q/Q-3.00%
Insider Own1.70%Inst Own52.90%
Insider Trans204.47%Inst Trans11.98%
Short Float0.75%EarningsMay 07/a
Analyst Recom2.00Target Price19.83
Avg Volume109.72K52W Range7.90 - 16.21
May-21-15 04:05PMAutobytel Acquires Dealix, a Top-Ranked Provider of Auto Sales Leads, for $25 Million GlobeNewswire
May-15-15 01:04PMAUTOBYTEL INC Financials
May-13-15 08:31AMFalling Earnings Estimates Signal Weakness Ahead for Autobytel (ABTL) - Tale of the Tape
May-12-15 01:38PMAUTOBYTEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
May-11-15 09:00AMInnovative Approach to Car Sales Clinches Autobytel Dealer of the Month Award for Three Dealer Superstars GlobeNewswire
May-09-15 08:09PM10-Q for Autobytel, Inc. at Company Spotlight
May-07-15 07:22PMAutobytel posts 1Q profit AP
Autobytel Inc. operates as an automotive marketing services company in the United States. It assists automotive retail dealers and manufacturers to market and sell new and used vehicles to consumers through its programs. The company's products include new vehicle lead program, which allows consumers to submit requests for pricing and availability of specific makes and models; and used vehicle lead program that allows consumers to search for used vehicles, as well as finance lead program, which provides consumers vehicle financing opportunity and other services from dealers or finance institutions. It owns and operates an automotive Website, that offers consumers the information and tools to aid them with their automotive purchase decisions; and ability to submit inquiries requesting dealers to contact the consumers for purchasing or leasing vehicles. The company's products and services also comprise iControl by Autobytel, which allows dealers various options to filter and control vehicle leads; WebLeads+ that offers various coupon options, which display marketing messages to consumers visiting the dealer's Website; Email Manager that provides follow up emails on behalf of the dealers to consumers who have submitted leads; and Lead Call, which provides a live phone call to the dealer to ensure that the dealer contacts the consumer. In addition, it offers Payment Pro, a dealer Website conversion tool that offers consumers online monthly payment information; mobile products and services that facilitate communication between dealers and car buyers on smart phones and tablets; and SaleMove Products and Services, which allows auto dealers and manufacturers to interact with consumer through live video, audio, text based chat, or phone, as well as sells fixed placement advertising across its Website. The company was formerly known as Inc. Autobytel Inc. was founded in 1995 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Auto Holdings Ltd.10% OwnerApr 27Buy4.65400,0001,860,0001,475,268May 04 08:03 PM
Fuller Glenn EvanEVP, CLO, SECRETARYDec 03Buy10.904004,3606,400Dec 03 04:02 PM
FUCHS MICHAEL JDirectorDec 01Buy10.602,30024,39052,680Dec 02 03:34 PM
KAPLAN MARK NDirectorNov 25Buy10.801,00010,8007,000Nov 25 05:25 PM
CompanyPorter Bancorp Inc.
IndustryRegional - Southeast Banks
Market Cap29.01MEPS (ttm)1.58
P/E0.96EPS this Y648.30%
Forward P/E-EPS next Y-
PEG0.96EPS past 5Y9.70%
P/S0.75EPS next 5Y1.00%
P/B0.85EPS Q/Q125.00%
Dividend-Sales Q/Q-7.10%
Insider Own15.30%Inst Own22.20%
Insider Trans0.82%Inst Trans118.52%
Short Float0.41%EarningsApr 30/a
Analyst Recom3.00Target Price1.50
Avg Volume8.35K52W Range0.46 - 1.25
May-20-15 01:04PMPORTER BANCORP, INC. Financials
May-15-15 09:00AMLatest Buzz in the Financial Sector: Complementary Research on Porter Bancorp, Planet Payment, Bankwell Financial, Impac Mortgage and QCR Holdings PR Newswire
May-13-15 08:11PM10-Q for Porter Bancorp, Inc. at Company Spotlight
May-11-15 04:37PMPORTER BANCORP, INC. Files SEC form 10-Q, Quarterly Report
Apr-30-15 04:12PMPORTER BANCORP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
Apr-30-15 04:05PMPorter Bancorp, Inc. Reports $409,000 First Quarter 2015 Net Income Business Wire
Apr-28-15 08:14PM10-K for Porter Bancorp, Inc. at Company Spotlight
Apr-28-15 05:15PMPorter Bank has a plan to boost its stock price at
Mar-30-15 04:23PMPORTER BANCORP, INC. Files SEC form 10-K, Annual Report
Porter Bancorp, Inc. operates as the holding company for PBI Bank that provides commercial and personal banking products and services, and financial services in Central Kentucky and Louisville. The company offers deposit products, including checking, savings, and term certificate accounts, as well as NOW accounts, money market accounts, and fixed rate certificates. It provides commercial loans for equipment purchases, working capital, and other financing needs of business enterprises; and commercial real estate loans that include loans on properties occupied by the borrowers and on properties for commercial purposes, as well as construction and development loans secured by land under development, or homes and commercial buildings under construction. The company also offers residential real estate loans; consumer loans; agriculture loans secured by livestock, crops, and/or equipment; and other loans include loans to municipalities, loans secured by stock, and overdrafts. In addition, it provides drive-through banking facilities, automatic teller machines, night depository, personalized checks, credit and debit cards, Internet banking, electronic funds transfers through ACH services, domestic and foreign wire transfers, travelers' checks, cash management, vault services, lock box services, and loan and deposit sweep accounts. As of May 28, 2014, the company operated 18 full-service banking offices in Kentucky. Porter Bancorp, Inc. was founded in 1902 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Satterthwaite Norman MarcusDirectorMay 15Buy1.0622023349,079May 21 09:15 AM
Satterthwaite Norman MarcusDirectorMay 05Buy1.0027527548,859May 06 04:04 PM
Satterthwaite Norman MarcusDirectorMay 04Buy1.059,5009,97548,584May 06 04:04 PM
Satterthwaite Norman MarcusDirectorFeb 17Buy0.8665956739,084Feb 19 04:10 PM
Satterthwaite Norman MarcusDirectorFeb 11Buy0.844,0473,39938,425Feb 13 04:05 PM
CompanyReWalk Robotics Ltd.
IndustryMedical Appliances & Equipment
Market Cap159.93MEPS (ttm)-2.01
P/E-EPS this Y-65.80%
Forward P/E-EPS next Y7.60%
PEG-EPS past 5Y0.00%
P/S39.98EPS next 5Y-
P/B4.06EPS Q/Q65.80%
Dividend-Sales Q/Q-6.30%
Insider Own-Inst Own41.90%
Insider Trans-Inst Trans0.12%
Short Float8.99%EarningsMay 07/b
Analyst Recom1.70Target Price20.00
Avg Volume139.99K52W Range10.35 - 43.71
May-22-15Upgrade Canaccord Genuity Hold → Buy $11 → $17
May-22-15 01:53PMReWalk Robotics Up On Buy Rating, Stock Price Upgrade at Investor's Business Daily
May-22-15 08:56AMReWalk upgraded by Canaccord Genuity
May-21-15 07:00AMReWalk Robotics to Present at Jefferies 2015 Healthcare Conference on June 4th GlobeNewswire
May-12-15 03:45AMExoskeleton that helps paralyzed walk faces barrier in Japan
May-07-15 08:30AMRewalk Robotics Ltd Earnings Call scheduled for 8:30 am ET today
May-07-15 07:13AMReWalk reports 1Q loss
May-07-15 07:07AMQ1 2015 Rewalk Robotics Ltd Earnings Release - Before Market Open
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals. The company offers ReWalk Personal for everyday use to individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy to individuals with lower limb disabilities in the clinical rehabilitation environment. It is also developing ReWalkQ for individuals with quadriplegia. ReWalk Robotics Ltd. markets and sells its products directly to institutions and individuals in Germany and the United States, as well as through third-party distributors in other markets. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.
CompanyOncothyreon Inc
Market Cap307.89MEPS (ttm)-0.55
P/E-EPS this Y-3.20%
Forward P/E-EPS next Y-11.80%
PEG-EPS past 5Y3.40%
P/S-EPS next 5Y-
P/B2.79EPS Q/Q42.90%
Dividend-Sales Q/Q-
Insider Own0.10%Inst Own62.90%
Insider Trans389.49%Inst Trans15.70%
Short Float4.86%EarningsMay 11/a
Analyst Recom2.00Target Price3.50
Avg Volume1.78M52W Range1.41 - 3.60
May-22-15 06:01AMBiotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail! at TheStreet
May-19-15 01:04PMONCOTHYREON INC. Financials
May-19-15 08:35AMOncothyreon (ONTY) Looks Good: Stock Up 6.6% in Session - Tale of the Tape
May-19-15 08:32AMWhy Oncothyreon (ONTY) is Poised to Beat Earnings Estimates - Tale of the Tape
May-18-15 07:26AMWill Oncothyreon (ONTY) Continue to Surge Higher? - Tale of the Tape
May-14-15 04:55PMONCOTHYREON INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or By
May-14-15 03:08PMThe 5 Winners and Losers From ASCO Presentations at 24/7 Wall St.
May-13-15 08:11PM10-Q for Oncothyreon, Inc. at Company Spotlight
May-13-15 05:00PMJumpstart ASCO '15 With This Quick List of Hot Research Abstracts at TheStreet
Oncothyreon Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. Its clinical-stage product candidates include ONT-380, an orally active and selective small-molecule HER2 inhibitor, which is in two Phase 1b trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin; and ONT-10, a therapeutic vaccine in Phase 1 trial targeting the Mucin 1 peptide antigen (MUC1) for use in various cancer indications, including breast, thyroid, colon, stomach, pancreas, ovarian, and prostate, as well as certain types of lung cancer. The company is also developing Checkpoint kinase 1, a protein kinase in pre-clinical studies to inhibit tumor growth as single agents. In addition, it focuses on researching on Protocells, which are nanoparticles designed to enable the targeted delivery of various therapeutic agents, including nucleic acids, proteins, peptides, and small molecules, as well as to develop product candidates for the treatment of cancer and rare diseases. The company has a research collaboration agreement with Sentinel Oncology Ltd. for the discovery of novel Chk1 inhibitors; collaboration with Celldex Therapeutics, Inc. on a combined clinical trial of ONT-10 and varlilumab; and collaboration with Adimab LLC for the discovery of novel antibodies against undisclosed immunotherapy targets in oncology. Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPIEGELMAN DANIEL KDirectorMar 26Buy1.5910,00015,85640,644Apr 01 07:28 PM
SPIEGELMAN DANIEL KDirectorMar 25Buy1.6310,00016,27130,644Apr 01 07:28 PM
BVF PARTNERS L P/IL10% OwnerDec 17Buy1.73153,495266,0226,362,683Dec 17 06:10 PM
BVF PARTNERS L P/IL10% OwnerDec 15Buy1.88224,949422,6576,264,385Dec 17 06:10 PM
TickerFRS [AMEX]
CompanyFrisch's Restaurants, Inc.
Market Cap172.83MEPS (ttm)2.15
P/E15.67EPS this Y34.10%
Forward P/E-EPS next Y-
PEG-EPS past 5Y4.80%
P/S0.80EPS next 5Y-
P/B1.76EPS Q/Q40.60%
Dividend2.37%Sales Q/Q4.20%
Insider Own0.10%Inst Own59.30%
Insider Trans0.00%Inst Trans0.43%
Short Float0.18%EarningsApr 08/b
Analyst Recom1.00Target Price28.00
Avg Volume2.53K52W Range20.94 - 30.22
May-22-15 08:00PMSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Frisch's Restaurants, Inc. And Encourages Investors To Contact The Firm For Additional Information PR Newswire
May-22-15 04:38PMPrivate equity fund buying Cincinnati-based Frisch's
May-22-15 01:35PMSHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Frisch's Restaurants Inc. - FRS PR Newswire
May-22-15 01:15PMHarwood Feffer LLP Announces Investigation of Frisch's Restaurants, Inc. PR Newswire
May-22-15 01:10PMFRS INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Frisch's Restaurants, Inc. in Connection With the Sale of the Company to NRD Partners - FRS PR Newswire
May-22-15 11:37AMFRISCH'S RESTAURANTS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
May-22-15 11:32AMFRISCHS RESTAURANTS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to NRD Partners Private Equity Fund Affiliate Business Wire
May-22-15 10:31AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Frischs Restaurants, Inc. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to NRD Partners Business Wire
May-22-15 09:48AMFRISCH'S SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Frisch's Restaurants, Inc. (FRS) Over the Proposed Sale of the Company to NRD Partners Private Equity Fund Affiliate PR Newswire
Frisch's Restaurants, Inc., together with its subsidiaries, operates full service family-style restaurants under the Frisch's Big Boy name in various regions of Ohio, Kentucky, and Indiana. As of June 3, 2014, it operated 96 restaurants and licensed 25 restaurants to other operators. The company was founded in 1923 and is headquartered in Cincinnati, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hansen Stephen J.VP - COMMISSARYNov 28Option Exercise11.051,16712,8953,957Dec 02 01:31 PM
Kelley Lindon CharlesRegional DirectorSep 10Option Exercise21.9050010,9503,789Sep 12 03:05 PM
GEEDING DANIEL WDirectorSep 08Option Exercise15.901,00015,90017,624Sep 10 10:13 AM
REIK WILLIAM J JRDirectorAug 29Option Exercise15.901,00015,900223,482Sep 03 04:38 PM
TickerCTRP [NASD] International Ltd.
Market Cap12.02BEPS (ttm)0.22
P/E384.68EPS this Y-75.70%
Forward P/E66.01EPS next Y287.31%
PEG7.97EPS past 5Y-19.10%
P/S10.14EPS next 5Y48.28%
P/B7.70EPS Q/Q-192.90%
Dividend-Sales Q/Q32.80%
Insider Own13.92%Inst Own88.10%
Insider Trans0.00%Inst Trans1.02%
Short Float6.39%EarningsMay 13/a
Analyst Recom2.00Target Price80.11
Avg Volume2.86M52W Range40.74 - 76.00
May-22-15 06:23PMCtrip May Tighten Grip On China Boom After Taking Stake In Rival Site eLong
May-22-15 02:25PMStrategic Deal Sends Ctrip Shares Into Orbit
May-22-15 01:48PMCtrip Rallies as Elong Purchase Cools Chinese Travel Competition at Bloomberg
May-22-15 01:33PMExpedia Sells Off eLong Stake in $671 Million Deal at TheStreet
May-22-15 01:30PMStocks Mixed; Shake Shack On Fire For 6th Straight Day at Investor's Business Daily
May-22-15 12:47PMExpedia Dumps Majority Stake In eLong
May-22-15 12:05PMNetEase Vaults Into Online Travel Vs. Ctrip, Qunar at Investor's Business Daily
May-22-15 11:25AMCtrip, Expedia Are Both Winners In eLong Sale at Investor's Business Daily
May-22-15 11:06AMExpedia Reaches Record After Selling Stake in Chinas ELong at Bloomberg International, Ltd., together with its subsidiaries, provides travel services for hotel accommodations, transportation ticketing services, packaged tours, and corporate travel management in the People's Republic of China. It also offers independent leisure travelers bundled packaged-tour products, including group tours, semi-group tours, and private tours or packaged tours with various transportation arrangements, such as cruise, bus, or self-driving. In addition, the company provides integrated transportation and accommodation services; various value-added services, including transportation at destinations and tickets, insurance, visa services, and tour guides; supplier management and customer relationship management services; and car rental services. Further, it offers Internet-related advertising, aviation and train insurance selling, air-ticket delivery, online check-in, and online seat selection and flight dynamics services; and sells Property Management System, a hotel information software, as well as provides related maintenance services. International, Ltd. was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
CompanyAchaogen, Inc.
Market Cap122.92MEPS (ttm)-1.29
P/E-EPS this Y-71.10%
Forward P/E-EPS next Y-18.30%
PEG-EPS past 5Y0.00%
P/S6.50EPS next 5Y-
P/B2.04EPS Q/Q66.00%
Dividend-Sales Q/Q-18.30%
Insider Own0.40%Inst Own86.50%
Insider Trans0.00%Inst Trans-0.84%
Short Float3.39%Earnings-
Analyst Recom2.00Target Price16.14
Avg Volume155.92K52W Range5.30 - 17.31
May-21-15 12:40PM5 Stocks Under $10 Set to Soar at TheStreet
May-20-15 01:04PMACHAOGEN INC Financials
May-11-15 04:52PMACHAOGEN INC Files SEC form 10-Q, Quarterly Report
May-11-15 04:20PMAchaogen Provides Clinical Update and First Quarter 2015 Results GlobeNewswire
May-08-15 08:29AMWhy Earnings Season Could Be Great for Achaogen, Inc. (AKAO) - Tale of the Tape
May-05-15 04:20PMAchaogen to Present at the Bank of America Merrill Lynch 2015 Health Care Conference GlobeNewswire
Apr-30-15 05:30AMAchaogen to Receive $7.1 Million in Settlement of Claim With Defense Threat Reduction Agency (DTRA) GlobeNewswire
Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant gram-negative infections in the United States. The company is principally developing plazomicin, which is in Phase III combating antibiotic resistant enterobacteriaceae trials for the treatment of bacterial infections due to multi-drug resistant Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the research and development of antipseudomonal LpxC inhibitor compounds that target infections caused by acinetobacter baumannii and pseudomonas aeruginosa. The company was incorporated in 2002 and is headquartered in South San Francisco, California.
CompanyCellular Biomedicine Group Inc.
Market Cap410.57MEPS (ttm)-1.38
P/E-EPS this Y27.00%
Forward P/E-EPS next Y11.20%
PEG-EPS past 5Y-20.20%
P/S684.29EPS next 5Y-
P/B9.14EPS Q/Q-50.00%
Dividend-Sales Q/Q300.00%
Insider Own-Inst Own3.10%
Insider Trans-Inst Trans-
Short Float2.88%EarningsMay 18
Analyst Recom1.00Target Price33.50
Avg Volume127.29K52W Range5.00 - 49.00
May-22-15 01:48PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cellular Biomedicine Group Inc. of Class Action Lawsuit and Upcoming Deadline - CBMG PR Newswire
May-22-15 09:17AMCellular Biomedicine Group Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program GlobeNewswire
May-22-15 09:17AM9:17 am Cellular Biomedicine announces 'encouraging' clinical data from its Chimeric Antigen Receptor CD30-positive Hodgkin's lymphoma immuno-oncology clinical development program
May-20-15 11:28AMINVESTOR ALERT: Investigation of Cellular Biomedicine Group Inc. Announced by The Law Offices of Howard G. Smith Business Wire
May-18-15 04:46PMSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Cellular Biomedicine Group Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit CBMG GlobeNewswire
May-18-15 06:23AMCellular Biomedicine reports 1Q loss
May-18-15 06:10AMCellular Biomedicine Group Reports First Quarter 2015 Financial Results and Provides Business Highlights GlobeNewswire
May-15-15 12:20PMCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-Q, Quarterly Report
Cellular Biomedicine Group, Inc., a biomedicine company, develops treatments for cancerous and degenerative diseases in Greater China. The company operates through two segments, Biomedicine and Consulting. It focuses on developing and marketing cell-based therapies to treat serious chronic and degenerative diseases, such as cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint degeneration and metabolic diseases. The company develops treatments utilizing proprietary cell technologies comprising tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. It also provides consulting services to companies who seek access to the U.S. capital markets. The company is headquartered in Palo Alto, California.
CompanyYouku Tudou Inc.
IndustryInternet Information Providers
Market Cap5.97BEPS (ttm)-0.72
P/E-EPS this Y-22.40%
Forward P/E-EPS next Y31.10%
PEG-EPS past 5Y13.30%
P/S8.75EPS next 5Y-
P/B2.62EPS Q/Q-450.00%
Dividend-Sales Q/Q54.80%
Insider Own8.46%Inst Own51.10%
Insider Trans0.00%Inst Trans3.06%
Short Float12.37%EarningsMay 20/a
Analyst Recom2.70Target Price137.64
Avg Volume3.44M52W Range11.85 - 27.40
May-22-15 01:48PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Youku Tudou, Inc. of Class Action Lawsuit and Upcoming Deadline - YOKU Marketwired
May-21-15 02:09PMYouku Tudou (YOKU) Stock Soaring After Issuing Second Quarter Outlook at TheStreet
May-21-15 07:22AMYouku Tudou Outlook, Price Target Increased At Brean
May-20-15 09:00PMYouku Tudou Inc Earnings Call scheduled for 9:00 pm ET today
May-20-15 06:00PMYouku Tudou Announces First Quarter 2015 Unaudited Financial Results PR Newswire
May-20-15 11:36AMYouku Earnings Preview: What Wall Street Has To Say
May-20-15 07:07AMQ1 2015 Youku Tudou Inc Earnings Release - After Market Close
May-19-15 08:30AMHagens Berman Reminds Investors With Losses Greater Than $100,000 in Youku Tudou, Inc. (NYSE: YOKU) of May 26th Lead Plaintiff Deadline GlobeNewswire
May-18-15 09:30AMThe Zacks Analyst Blog Highlights: Netflix, Alibaba Group, Google and Youku Tudou - Press Releases
Youku Tudou Inc. operates as an Internet television company in the People's Republic of China. Its Internet television platform enables users to search, view, and share video content across various devices. The company's services for users comprise online video content library consisting primarily of professionally produced content, including television serial dramas, movies, current event reports, variety shows, and music videos. It also provides guided user-generated content through Youku Paike and Youku Niuren programs; and produces a range of content, such as sponsored Web serial dramas, reality shows, interviews, and variety shows under the Youku Originals brand, as well as on Tudou platform. The company's other services for users include online video search and discovery; online community services; Youku VIP services; mobile video services; cloud entertainment services; and Laifeng, an interactive broadcasting platform, which features user-generated live content related to original shows, such as The Show and Searching for Divas. In addition, it offers online advertising services to various advertising companies operating in food and beverage, automobile manufacturing, financial services, personal care, e-commerce, information technology services, electronics, and Internet services. The company's products and services for advertisers and customers comprise online advertising services, such as in-video, display, sponsorship, and other forms of advertisements; targeting solutions; viral video advertisements; product placements; and sub-licensing content and mobile value-added services. Further, it offers technology consulting and administrative, and advertising and copy right agency services; and engages in film and television production and distribution. The company was formerly known as Youku Inc. and changed its name to Youku Tudou Inc. in August 2012. Youku Tudou Inc. was founded in 2005 and is headquartered in Beijing, the People's Republic of China.
CompanyeHi Car Services Limited
IndustryRental & Leasing Services
Market Cap914.47MEPS (ttm)-6.27
P/E-EPS this Y-449.50%
Forward P/E22.24EPS next Y203.38%
PEG-EPS past 5Y0.00%
P/S6.66EPS next 5Y-
P/B1.22EPS Q/Q54.30%
Dividend-Sales Q/Q-56.50%
Insider Own-Inst Own33.10%
Insider Trans-Inst Trans3.27%
Short Float8.41%EarningsApr 01/a
Analyst Recom2.50Target Price13.45
Avg Volume118.79K52W Range7.91 - 15.55
May-22-15 07:56AMTiger Global, SRS to Invest in eHi at The Wall Street Journal
May-22-15 06:24AM6:24 am eHi Car Services announces definitive agreements to sell up to ~22.34 mln common stock shares, at $12.00/ADS
May-22-15 06:22AMeHi Car Services Announces Private Placement of Common Stock PR Newswire
May-19-15 04:30PMeHi Car Services to Report First Quarter 2015 Results after U.S. Markets Close on May 26, 2015 PR Newswire
Apr-28-15 01:04PMEHI CAR SERVICES LTD Financials
Apr-23-15 04:30AMeHi Car Services Files Its Annual Report on Form 20-F PR Newswire
Apr-01-15 05:00PMeHi Car Services Announces Fourth Quarter and Full Year 2014 Results PR Newswire
eHi Car Services Limited, through its subsidiaries, provides car rentals and car services in the People's Republic of China. The company offers self-drive car rental services to individual customers and corporate clients. It also provides car services, including airport pickup and drop-off, inter-office transfers, and other business transportation services, as well as services for event-driven activities, such as conventions, promotional tours, and special events to corporate clients. As of December 31, 2014, the company had a car rental fleet of 18,416 vehicles; and car services fleet of approximately 1,330 vehicles and drivers. eHi Car Services Limited was founded in 2006 and is headquartered in Shanghai, the People's Republic of China.
1 2 3 4 5 6 7 8 9 next